News & Analysis - CNBC

1. Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

2. China blocks Meta's $2 billion acquisition of AI startup Manus

3. This bank CEO let his AI clone handle an earnings call — now he's signing an OpenAI deal

4. MAHA is mad. Its alliance with Trump is about to face its biggest test

5. United Airlines CEO confirms he approached American Airlines about merger

6. The bullish signals ahead of this week's Mag-7 earnings

7. Wall Street expects solid Q1 results for GM, as Ford and Stellantis try to gain traction

8. Everything we know about Cole Allen, the suspected DC correspondents' dinner gunman

9. Some young Americans scale back dating as costs and apps add pressure, survey shows

10. Purple ube’s viral rise is turning a Filipino staple into a global trend — but supplies are tightening

11. Sun Pharma shares jump 7% as India's largest drugmaker to buy U.S. firm Organon in $11.75 billion deal

12. AI bill would crack down on deepfake distribution and protect whistleblowers

13. We spoke to over 30 CEOs and business leaders. Here's what worries them most

14. Insurance rates based on credit history draw scrutiny from lawmakers in some states

15. Cramer: Why all the money flowing to AI stocks is a problem — and how it can be fixed

16. From car and phone to tractor owners, a populist wave is rising to end the 'captive' repair economy

17. We tried out xAI's Grok chatbot while driving a Tesla in NYC. Here's what happened.

18. Europe’s rearmament push drives global military spending to record $2.9 trillion despite U.S. pullback

19. Forgotten no more: Generation X is driving beauty sales